ABOUT
India’s First allogenic stromal cell therapy product
Mothercell Regenerative Centre (MCRC) , a clinical-stage regenerative medicine company, is focused on developing innovative cell based therapeutics that are clinically impactful, accessible, and practical for any patient. MCRC has developed Protocols for autologous and allogenic application of biologics, an innovative biologic platform that harnesses the therapeutic power of chemokines , exosomes and secretomes as a truly shelf-stable remedy that are needed for regenerative medicine.
Along with cell based therapy the company is currently evaluating human plasma derived growth factors for the treatment of wound healing, cardiovascular disease, hair regeneration, male & female infertility, erectile dysfunction, neurological disorders and pelvic floor disorders. MCRC works in hand with Indian Stem Cell Study Group (ISCSG) to implement clinical protocols towards Regenerative approach in the treatment of Critical limb ischemia (CLI), Osteoarthritis (OA) Knee & Rheumatoid arthritis (RA).
